A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease.
<h4>Background</h4>Fecal calprotectin (FC) is widely used for the diagnosis and monitoring disease activity of inflammatory bowel disease (IBD). Quantitative rapid assays can be a reliable alternative to the time-consuming assay. This study aimed to evaluate and compare the diagnostic pe...
Guardado en:
Autores principales: | Jong-Mi Lee, Joo Hee Jang, Ji Hyeong Ryu, Jaeeun Yoo, Bo-In Lee, Seung-Jun Kim, Eun-Jee Oh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1a2dc459e8a74099aee5e883aa7926cd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
por: Cao Y, et al.
Publicado: (2021) -
Fecal calprotectin and microbiota of the gut
por: V. G. Gorokhova, et al.
Publicado: (2016) -
Fecal calprotectin in healthy children aged 4–16 years
por: María Roca, et al.
Publicado: (2020) -
Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms
por: Hajar Shokri-Afra, et al.
Publicado: (2021) -
The fecal mycobiome in patients with Irritable Bowel Syndrome
por: A. Das, et al.
Publicado: (2021)